The year 2026 marks a significant shift in how adolescent depression is managed, with a move toward "stepped-care" interventions. As school-based mental health programs expand globally, there is an increasing demand for pharmacological options that have a proven safety record in younger populations. Regulatory bodies in the US and UK are currently reviewing updated safety data for dual-reuptake...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Tiếng Việt